Experience of Visual Perception in the Design Education

Relevance of the paper is due to theoretical and practical necessity to study the peculiarities of design education. Modern designer shall, theoretically and methodologically, master the system of design engineering based on the laws affecting the form of product, methods of styling design and design quality analysis, basics of materials science and industrial design engineering. Design of industrial products shall draw upon historical, cultural, logistical, aesthetic and artistic foundations. The paper applies methods of cultural and historical analysis, comparative methods, methods of analysis and simulation of semiotic systems. Authors, emphasizing training process integrity for design specialists, pay attention to the fact that in the modern urban world requirements to visual aesthetics are particularly important, ensuring videoecology of objects and environment, creating maximum emotional comfort. Ability to create emotional environment is due to form quality, generating peculiarities of psychological reactions as emotions. The study of form perception revealed the mechanism of creating emotional response associated with semantic capacity of design object and special features of its visual organization. Perception model of visual images in design was suggested, including recognition, comparison and dialogue processes. The findings are scientifically-based recommendations, tailored to visual perception and aimed at creating emotional comfort in design

High-Voltage Signal Generator for Biomedical Applications

Electroporation is the process where externally applied electric fields cause significantly increased permeability of the cell membrane. The increased permeability allows the transport of external compounds into the cell. This is important for applications in electrochemotheropy, electrofusion and drug delivery. Electroporation also has applications in the disinfection of liquids. Given a high enough electric field across the cell membrane, the electroporation process can become irreversible, leading to cell destruction. With the cell membrane under an intense electric field, the cell membrane structure fails causing the cell to die. Conventional liquid beverage disinfection systems rely on slow heating methods requiring large power requirements; this can reduce the taste and quality of some liquids. Pulse generators provide the necessary electric fields to produce the required voltage potential across the cell membrane. The usefulness of electroporation depends on several parameters such as amplitude, frequency and rise/fall times of the electric field. The wave shape also has a bearing on performance, and is limited by the pulse generator topology. A multilevel bipolar waveform is desired with operating frequencies above about 1 kHz. The cascaded H-bridge or full-bridge topology is the most useful as it capable of producing multilevel bipolar waveforms at high frequency. This thesis presents the design and implementation of a multilevel high-voltage pulse generator, capable of creating very high-voltage AC pulses. MOSFET switching devices in conjunction with good layout practices were used to provide required fast switching speeds. The full-bridge topology is used to create a multilevel output profile through cascading of multiple stages. As a full-bridge topology inherently creates a RCL resonant network, there are many challenges associated with mitigating high-frequency noise sources. Two separate stages are built, a low voltage stage capable of outputting up to 200 Vp and a high voltage stage capable of switching up to 1 kVp. A control board was also built for pulse signal generation and user configuration of the output waveforms. The designed pulse generator can produce short pulses of up to 1.4 kVp at frequencies of up to 350 kHz using primarily resistive loads (that simulate a conductive liquid load). Little high frequency switching noise was observable on the output waveform. A single stage pulse generator was also tested with actual liquid loads using an electrode chamber, demonstrating electroporation. The liquid load testing was performed on water and milk derived from milk powder. Results showed that the liquid loads were consistent with primarily resistive loads

Circulating Folate and Vitamin B12 and Risk of Prostate Cancer: A Collaborative Analysis of Individual Participant Data from Six Cohorts Including 6875 Cases and 8104 Controls.

BACKGROUND: Folate and vitamin B12 are essential for maintaining DNA integrity and may influence prostate cancer (PCa) risk, but the association with clinically relevant, advanced stage, and high-grade disease is unclear. OBJECTIVE: To investigate the associations between circulating folate and vitamin B12 concentrations and risk of PCa overall and by disease stage and grade. DESIGN, SETTING, AND PARTICIPANTS: A study was performed with a nested case-control design based on individual participant data from six cohort studies including 6875 cases and 8104 controls; blood collection from 1981 to 2008, and an average follow-up of 8.9 yr (standard deviation 7.3). Odds ratios (ORs) of incident PCa by study-specific fifths of circulating folate and vitamin B12 were calculated using multivariable adjusted conditional logistic regression. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Incident PCa and subtype by stage and grade. RESULTS AND LIMITATIONS: Higher folate and vitamin B12 concentrations were associated with a small increase in risk of PCa (ORs for the top vs bottom fifths were 1.13 [95% confidence interval (CI), 1.02-1.26], ptrend=0.018, for folate and 1.12 [95% CI, 1.01-1.25], ptrend=0.017, for vitamin B12), with no evidence of heterogeneity between studies. The association with folate varied by tumour grade (pheterogeneity0.05). Use of single blood-sample measurements of folate and B12 concentrations is a limitation. CONCLUSIONS: The association between higher folate concentration and risk of high-grade disease, not evident for low-grade disease, suggests a possible role for folate in the progression of clinically relevant PCa and warrants further investigation. PATIENT SUMMARY: Folate, a vitamin obtained from foods and supplements, is important for maintaining cell health. In this study, however, men with higher blood folate levels were at greater risk of high-grade (more aggressive) prostate cancer compared with men with lower folate levels. Further research is needed to investigate the possible role of folate in the progression of this disease

The trans-ancestral genomic architecture of glycemic traits

Glycemic traits are used to diagnose and monitor type 2 diabetes and cardiometabolic health. To date, most genetic studies of glycemic traits have focused on individuals of European ancestry. Here we aggregated genome-wide association studies comprising up to 281,416 individuals without diabetes (30% non-European ancestry) for whom fasting glucose, 2-h glucose after an oral glucose challenge, glycated hemoglobin and fasting insulin data were available. Trans-ancestry and single-ancestry meta-analyses identified 242 loci (99 novel; P < 5 x 10(-8)), 80% of which had no significant evidence of between-ancestry heterogeneity. Analyses restricted to individuals of European ancestry with equivalent sample size would have led to 24 fewer new loci. Compared with single-ancestry analyses, equivalent-sized trans-ancestry fine-mapping reduced the number of estimated variants in 99% credible sets by a median of 37.5%. Genomic-feature, gene-expression and gene-set analyses revealed distinct biological signatures for each trait, highlighting different underlying biological pathways. Our results increase our understanding of diabetes pathophysiology by using trans-ancestry studies for improved power and resolution. A trans-ancestry meta-analysis of GWAS of glycemic traits in up to 281,416 individuals identifies 99 novel loci, of which one quarter was found due to the multi-ancestry approach, which also improves fine-mapping of credible variant sets.Peer reviewe

The Changing Landscape for Stroke\ua0Prevention in AF: Findings From the GLORIA-AF Registry Phase 2

Background GLORIA-AF (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation) is a prospective, global registry program describing antithrombotic treatment patterns in patients with newly diagnosed nonvalvular atrial fibrillation at risk of stroke. Phase 2 began when dabigatran, the first non\u2013vitamin K antagonist oral anticoagulant (NOAC), became available. Objectives This study sought to describe phase 2 baseline data and compare these with the pre-NOAC era collected during phase&nbsp;1. Methods During phase 2, 15,641 consenting patients were enrolled (November 2011 to December 2014); 15,092 were eligible. This pre-specified cross-sectional analysis describes eligible patients\u2019 baseline characteristics. Atrial fibrillation&nbsp;disease characteristics, medical outcomes, and concomitant diseases and medications were collected. Data were analyzed using descriptive statistics. Results Of the total patients, 45.5% were female; median age was 71 (interquartile range: 64, 78) years. Patients were from Europe (47.1%), North America (22.5%), Asia (20.3%), Latin America (6.0%), and the Middle East/Africa (4.0%). Most had high stroke risk (CHA2DS2-VASc [Congestive heart failure, Hypertension, Age&nbsp; 6575 years, Diabetes mellitus, previous Stroke, Vascular disease, Age 65 to 74 years, Sex category] score&nbsp; 652; 86.1%); 13.9% had moderate risk (CHA2DS2-VASc&nbsp;= 1). Overall, 79.9% received oral anticoagulants, of whom 47.6% received NOAC and 32.3% vitamin K antagonists (VKA); 12.1% received antiplatelet agents; 7.8% received no antithrombotic treatment. For comparison, the proportion of phase 1 patients (of N&nbsp;= 1,063 all eligible) prescribed VKA was 32.8%, acetylsalicylic acid 41.7%, and no therapy 20.2%. In Europe in phase 2, treatment with NOAC was more common than VKA (52.3% and 37.8%, respectively); 6.0% of patients received antiplatelet treatment; and 3.8% received no antithrombotic treatment. In North America, 52.1%, 26.2%, and 14.0% of patients received NOAC, VKA, and antiplatelet drugs, respectively; 7.5% received no antithrombotic treatment. NOAC use was less common in Asia (27.7%), where 27.5% of patients received VKA, 25.0% antiplatelet drugs, and 19.8% no antithrombotic treatment. Conclusions The baseline data from GLORIA-AF phase 2 demonstrate that in newly diagnosed nonvalvular atrial fibrillation patients, NOAC have been highly adopted into practice, becoming more frequently prescribed than VKA in&nbsp;Europe and North America. Worldwide, however, a large proportion of patients remain undertreated, particularly in&nbsp;Asia&nbsp;and North America. (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients With Atrial Fibrillation [GLORIA-AF]; NCT01468701